Chinese doctors trial plasma therapy on COVID-19 patients

WHO has backed the therapy using convalescent plasma as a 'valid approach'

Doctors in Shanghai are using hyperimmune globulin from plasma of patients who have recovered from COVID-19 to treat those fighting the infection, with some “encouraging preliminary results”.

COVID-19

As of Monday, in Shanghai, China's financial hub, there had been 332 infected cases. One of those cases has died.

Professor Lu Hongzhou, co-director of the Shanghai Public Health Clinical Centre, said that 184 cases were still hospitalised, including 166 mild cases, while 18 were in serious and critical conditions.

Latest